Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress

This Biosimilars and Biologics Congress 2019 will bring together scientists, researchers, business development managers, CEOs, directors, IP attorneys, regulatory officials and CROs from around the world. Many biologics products are making their entry in the pharma market and experiencing a notable rise in their usage over the conventional medications.

At Biosimilars 2019 meet your target audiences from around the world focused on learning about biologics and biosimilars. This conference is one of the best opportunities to reach the largest assemblage of participants from the biosimilars and biologics community.

Sessions include:

• Challenges in Biosimilars and Biologics Development
• Challenges in Bioanalytical Assays for Biosimilars
• Biologics as therapeutics
• Emerging Biosimilars and research pipelines
• Monoclonal Antibody and Fusion Protein Biosimilars
• Biogenerics and Biopharmaceuticals
• Biosimilars Clinical Research and Pharmacovigilance
• Globalization of Biosimilars
• Clinical trial development for Biosimilars
• Evolution of Biologics in Inflammatory Medicine

Key note speakers:

• Sameer Agarwal (CSA Healthcare, CEO and Managing Partner, Germany)
• Raewyn Mai (Griffith University, Australia)
• Roland Meisel (BLAC-BioPharma UG, CEO and Founder, Germany)